Due to the COVID-19 pandemic, these meetings are being replaced with a webinar in Autumn 2020.
Sign up for more information when it becomes available.

Future webinar

How to optimise therapy for cardiorenal patients

A focus on RAAS inhibition and hyperkalaemia management

  •   Introduction
  •   Hyperkalaemia in patients with heart failure and optimising RAAS inhibition
  •   Case-based MDT discussion and questions
  •   Hyperkalaemia in the world of the nephrologist
  •   Case-based MDT discussion and questions
  •   Don’t let hyperkalaemia get you down
  •   Case-based MDT discussion and questions
  •   Meeting close

What are they about?

We have been listening to your feedback that you would like more case-based and practical learning. We are delighted to be able offer these new webinars, led by experts in the field, that will discuss the practical approach to the management of hyperkalaemia in patients with cardiorenal disease.

This will include the approach to broad-spectrum presentations, from those with potentially life-threatening hyperkalaemia through to the impact of high potassium on the use of prognostically important renin-angiotensin-aldosterone system (RAAS) inhibitors. Using case examples, they will discuss and guide on how to optimally manage such patients and avoid pitfalls that might have adverse consequences to patients. Wherever possible, local pathways will be used and multidisciplinary discussion encouraged.

At the end of each webinar, delegates will have learned/contributed to multidisciplinary discussion around the following topics:

  • The prevalence of hyperkalaemia, its potential causes, presentation, and association with adverse outcomes
  • The prognostic benefit of RAAS inhibitors in patients with chronic heart failure and those with CKD and how hyperkalaemia may influence their prescription
  • The role of potassium binders in managing acute hyperkalaemia and facilitating the use of RAAS inhibitors
  • What national and international guidelines say
  • Review of local guidelines – are they contemporary?
  • Practical advice on how to manage hyperkalaemia in hospital and in the community
  • Multidisciplinary discussion around case histories including special groups, and clinical questions

Sign up for more information

Who can attend?

These webinars can only be attended by healthcare professionals. They are aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, care of the elderly, general medicine, general practitioners, clinical pharmacists and allied disciplines.


We thank Vifor Pharma UK for their award of an unrestricted educational grant to support this webinar.